Eribulin Mesylate

List of products in the National Drug Code with proprietary name eribulin mesylate. Eribulin is used to treat certain types of cancer (breast, liposarcoma). It works by slowing or stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0143-9167Eribulin Mesylate Eribulin MesylateInjectionIntravenousHikma Pharmaceuticals Usa Inc.Human Prescription Drug
0781-3391Eribulin Mesylate Eribulin MesylateInjectionIntravenousSandoz IncHuman Prescription Drug
10019-080Eribulin Mesylate Eribulin MesylateInjectionIntravenousBaxter Healthcare CompanyHuman Prescription Drug
40033-364Eribulin Mesylate Eribulin MesylateInjectionIntravenousKindos Pharmaceuticals Co., Ltd.Human Prescription Drug
60505-6289Eribulin Mesylate Eribulin MesylateInjectionIntravenousApotex Corp.Human Prescription Drug
60505-6435Eribulin Mesylate Eribulin MesylateInjectionIntravenousApotex Corp.Human Prescription Drug
68083-592Eribulin Mesylate Eribulin MesylateInjectionIntravenousGland Pharma LimitedHuman Prescription Drug
70095-080Eribulin Mesylate Eribulin MesylateInjectionIntravenousSun Pharmaceutical Industries LimitedHuman Prescription Drug
71731-4171Eribulin Mesylate Eribulin MesylateInjectionIntravenousChia Tai Tianqing Pharmaceutical Group Co., Ltd.Human Prescription Drug
81298-3890Eribulin Mesylate Eribulin MesylateSolutionIntravenousLong Grove Pharmaceuticals, LlcHuman Prescription Drug